World Journal of Cardiology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Batta A, Hatwal J. Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern! World J Cardiol 2024; 16(7): 380-384 [PMID: 39086893 DOI: 10.4330/wjc.v16.i7.380]
URL:	https://www.wjgnet.com/1949-8462/full/v16/i7/380.htm

(96) (125) (0) (0) (0) (9) (2286) (17)

Number	Citing Articles
1	Yanqiu Huang, Yadan Xu, Chenghao Zhang, Wen Gu, Yue Li, Haojia Zhang, Tian Wang, Tangyi Su, Yangchen Lhamu, Yichen Chen, Liang Zhou, Lipeng Hao, Yang Yang, Hui Wang. Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study. Cardiovascular Diabetology 2026; 25(1) doi: 10.1186/s12933-026-03208-x
2	Sajid Jalil, Mangesh Pagadala, Nicholas Dunn, Hanna Blaney, Mohamed Elfeki, Nimish Thakral, Ashwani K. Singal. Transient Elastography and Fibroscan: Stethoscope of a Hepatologist in Today’s World. Current Hepatology Reports 2025; 24(1) doi: 10.1007/s11901-025-00713-7
3	Carlo Acierno, Riccardo Nevola, Fannia Barletta, Katarzyna Zielińska, Luca Rinaldi, Ferdinando Carlo Sasso, Caterina Conte, Luigi Elio Adinolfi, Alfredo Caturano. The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management. Exploration of Medicine 2025; 6 doi: 10.37349/emed.2025.1001365
4	Cong Chen, Jinming Chen, Jilin Chen. Perturbation of Circulating Inflammatory Proteins Mediates the Relationship Between Cholecystectomy and Nonalcoholic Fatty Liver Disease: A Multivariate and Mediation Mendelian Randomization Study. Health Science Reports 2025; 8(10) doi: 10.1002/hsr2.71303
5	Tobias Harm, Anne-Katrin Rohlfing, Jessica Kristin Henes, Nicole Manzat, Michal Droppa, Malte Bongers, Mathias Heikenwaelder, Karin Müller, Meinrad Gawaz, Dominik Rath. Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Inflammation Research 2025; doi: 10.2147/JIR.S533707
6	Ajit Singh Brar, Tejasvini Khanna, Aalam Sohal, Juniali Hatwal, Vishal Sharma, Carol Singh, Akash Batta, Praveen Chandra, Bishav Mohan. Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review. World Journal of Cardiology 2026; 18(1): 111954 doi: 10.4330/wjc.v18.i1.111954 Abstract(77) \| Core Tip(52) \| Full Article(HTML)(663) \| Full Article (PDF)-9960K(142) \| Full Article with Cover (PDF)-10215K(30) \| Full Article (XML)-545K(25) \| Audio-507K(13) \| Peer-Review Report-194K(19) \| Answering Reviewers-168K(22) \| Times Cited (8) \| Total Visits (979) \| Open
7	Kenneth Maiese. Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways. World Journal of Cardiology 2024; 16(11): 632-643 doi: 10.4330/wjc.v16.i11.632 Abstract(629) \| Core Tip(569) \| Full Article(HTML)(2373) \| Full Article (PDF)-949K(230) \| Full Article with Cover (PDF)-1202K(188) \| Full Article (XML)-554K(132) \| Audio-1118K(5) \| Peer-Review Report-221K(153) \| Answering Reviewers-61K(127) \| Times Cited (6) \| Total Visits (3328) \| Open
8	Li Fan, Yongkang Su, Yue Chen, Ling Xu, Hairong Huang, Chunsheng Lu, Jia Peng, Yingbin Sun, Min Jia. Triglyceride-cholesterol-body weight index associated with the risk of metabolic dysfunction-associated steatotic liver disease: a population-based cross-sectional study. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1698297
9	Anmol Singh, Aalam Sohal, Akash Batta. Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(39): 4324-4328 doi: 10.3748/wjg.v30.i39.4324 Abstract(609) \| Core Tip(611) \| Full Article(HTML)(3421) \| Full Article (PDF)-378K(226) \| Full Article with Cover (PDF)-637K(162) \| Full Article (XML)-76K(120) \| Audio-925K(8) \| Peer-Review Report-176K(124) \| Answering Reviewers-136K(113) \| Times Cited (11) \| Total Visits (3929) \| Open
10	Anmol Singh, Aalam Sohal, Akash Batta. GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis. World Journal of Gastroenterology 2024; 30(48): 5205-5211 doi: 10.3748/wjg.v30.i48.5205 Abstract(793) \| Core Tip(721) \| Full Article(HTML)(6834) \| Full Article (PDF)-395K(450) \| Full Article with Cover (PDF)-608K(221) \| Full Article (XML)-98K(128) \| Audio-1042K(9) \| Peer-Review Report-296K(111) \| Answering Reviewers-198K(113) \| Times Cited (36) \| Total Visits (8288) \| Open
11	Junyu Wang, Jingting Lei, Martin C. Harmsen, Han Moshage. From cooperation to collapse: systemic failure in liver disease through a sociological lens. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100580
12	Kathryn Thompson, William Breaux, Lesley S. Miller, John Nemeth, Sarah Koumtouzoua, Natasha Travis. Effect of common diabetes medications on metabolic dysfunction-associated steatotic liver disease as measured by transient elastography and other metabolic parameters: A systematic review. Clinics and Research in Hepatology and Gastroenterology 2026; 50(3) doi: 10.1016/j.clinre.2026.102784
13	Wen-Rui Hao, Chun-Han Cheng, Tzu-Hurng Cheng. Addressing the alarming link between nonalcoholic fatty liver disease and cardiovascular mortality in men. World Journal of Cardiology 2024; 16(9): 502-507 doi: 10.4330/wjc.v16.i9.502 Abstract(620) \| Core Tip(536) \| Full Article(HTML)(1697) \| Full Article (PDF)-380K(149) \| Full Article with Cover (PDF)-578K(126) \| Full Article (XML)-72K(124) \| Audio-187K(11) \| Peer-Review Report-249K(99) \| Answering Reviewers-90K(106) \| Times Cited (5) \| Total Visits (2096) \| Open
14	Ralf Weiskirchen. Resmetirom and semaglutide in metabolic dysfunction-associated steatohepatitis (MASH): a comparative perspective. Exploration of Drug Science 2025; 3 doi: 10.37349/eds.2025.1008132
15	Bharath V Karnati, Pradip Kumar Behera, Krishna P Tripathy, Rama Sowmya Karanam, Aparajita Priyadarshini, Swati Das, Subhashree Mishra. Association and Diagnostic Performance of the Atherogenic Index of Plasma and Carotid Intima-Media Thickness in Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study. Cureus 2026; doi: 10.7759/cureus.105774
16	Zhengjin Wang, Zhangxin Chen, Hanxu Zhuang. Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 2001–2018. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1528732
17	Amirmohammad Abolhassani, Mohammed H. Moghadasian, Niloofar Sedaghatnezhad, Sadegh Jafarnejad. Anti-Dyslipidemic, Anti-Hypertensive, and Glycemic Control Effects of Akkermansia Muciniphila: Lesser-Known Benefits in Metabolic Syndrome – A Narrative Review. Heart and Mind 2025; 9(5) doi: 10.4103/hm.HM-D-24-00161
18	Chenlu Yang, Shuohua Chen, Baoyu Feng, Ying Lu, Yanhong Wang, Wei Liao, Shouling Wu, Li Wang. Association between menopause, body composition, and nonalcoholic fatty liver disease: A prospective cohort in northern China. Maturitas 2025; 192 doi: 10.1016/j.maturitas.2024.108148

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.